Company Filing History:
1 out of 10 
1 out of 2 Years Active: 1998-1999
Title: Bart J Van Schie: Innovator in Eucaryotic Cell Growth
Introduction
Bart J Van Schie is a notable inventor based in Huizen, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the area of eucaryotic cell growth. With a total of 2 patents to his name, his work has the potential to impact various applications in research and industry.
Latest Patents
Van Schie's latest patents focus on methods and kits for in vitro cell growth of eucaryotic cells using hydrolyzates of protein materials. The first patent describes a method that utilizes a hydrolyzate containing peptides and free amino acids, specifically highlighting the importance of L-glutamine in concentrations greater than 20 percent by weight. Additionally, it specifies that ninety percent of the hydrolyzed protein material has a molecular weight of less than 1,000 kD, with a free amino acid level of less than 20 percent by weight and an average peptide length of less than 20 amino acids. The second patent reiterates these findings, emphasizing the same critical components for effective cell growth.
Career Highlights
Throughout his career, Bart J Van Schie has worked with prominent companies in the food and flavor industry. He has been associated with Quest International Flavors & Food Ingredients Company and its division, Quest International Flavors & Food Ingredients Co., Division of Indopco. His experience in these organizations has contributed to his expertise in developing innovative solutions for cell growth.
Collaborations
Some of his notable coworkers include Wim R Blom and Anthonie Kunst. Their collaborative efforts have likely played a role in advancing the research and development of eucaryotic cell growth methodologies.
Conclusion
Bart J Van Schie stands out as an inventor whose work in eucaryotic cell growth has the potential to influence various scientific and industrial applications. His patents reflect a commitment to advancing biotechnology, and his career highlights demonstrate his valuable contributions to the field.